Associate ProfessorUniversity of Texas MD Anderson Cancer Center
Disclosure information not submitted.
The PERIO-03 Trial: Technical Feasibility and Safety of a Novel Pancreatic Retrograde Venous Immunotherapy Infusion Intervention for Locally Advanced Pancreatic Ductal Adenocarcinoma
Sunday, March 24, 20244:21 PM – 4:30 PM MT